Cargando…
Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors
Developing therapeutics that target multiple receptor signaling pathways in tumors is critical as therapies targeting single specific biomarker/pathway have shown limited efficacy in patients with cancer. In this study, we extensively characterized a bi-functional molecule comprising of epidermal gr...
Autores principales: | Zhu, Yanni, Bassoff, Nicole, Reinshagen, Clemens, Bhere, Deepak, Nowicki, Michal O., Lawler, Sean E., Roux, Jérémie, Shah, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454031/ https://www.ncbi.nlm.nih.gov/pubmed/28572590 http://dx.doi.org/10.1038/s41598-017-02483-9 |
Ejemplares similares
-
Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers
por: Kitamura, Yohei, et al.
Publicado: (2021) -
Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy
por: Bhere, Deepak, et al.
Publicado: (2020) -
A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death
por: Bucur, Octavian, et al.
Publicado: (2015) -
Stem Cell Therapies: A Way to Promising Cures
por: Nawab, Khalid, et al.
Publicado: (2019) -
Stochastic Models of Lymphocyte Proliferation and Death
por: Zilman, Anton, et al.
Publicado: (2010)